HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth Saller Selected Research

Natural Cytotoxicity Triggering Receptor 1

11/2010IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabeth Saller Research Topics

Disease

2Neoplasms (Cancer)
11/2010 - 04/2008
1Cyanosis
01/2012
1Carcinoma (Carcinomatosis)
04/2008
1Breast Neoplasms (Breast Cancer)
04/2008

Drug/Important Bio-Agent (IBA)

1GlobinsIBA
01/2012
1Oxygen (Dioxygen)IBA
01/2012
1Natural Cytotoxicity Triggering Receptor 1IBA
11/2010
1Interleukin-12 (IL 12)IBA
11/2010
1Proteins (Proteins, Gene)FDA Link
04/2008
1Messenger RNA (mRNA)IBA
04/2008
1TamoxifenFDA LinkGeneric
04/2008
1Differentiation AntigensIBA
04/2008

Therapy/Procedure

1Immunotherapy
04/2008